Welcome to our dedicated page for QUANTASING GROUP SEC filings (Ticker: QSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QuantaSing Group Limited, now operating as Here Group Limited, files as a foreign private issuer using Form 20-F and Form 6-K reports. The filings document the company's transition to an IP-based pop toy company, Nasdaq name and ticker changes, ADS-related voting materials, and shareholder approvals from extraordinary general meeting materials.
Regulatory disclosures also cover unaudited financial results, annual report availability, capital-structure matters, and material reports tied to the company's Letsvan investment and pop toy operations. The record includes notices, proxy forms, depositary materials, and current reports that describe governance actions, shareholder voting mechanics, and foreign-issuer reporting obligations.
QuantaSing Group Limited Schedule 13G/A discloses that several GGV-sponsored entities and five GGV managing directors jointly report beneficial ownership of Class A ordinary shares as of June 30, 2025. The filing states ownership consists of 95,697 Class A shares (held as 31,899 ADSs) by GGV Capital VI Entrepreneurs Fund and 2,216,256 Class A shares (held as 738,752 ADSs) by GGV Discovery I, totaling reporting persons' shared voting and dispositive power over 2,311,953 Class A shares, equal to 2.2% of the class based on 103,776,127 shares outstanding as of June 30, 2024. Each ADS represents three Class A shares. The reporting persons disclaim status as a group and identify their jurisdictions and signatures certifying the report dated August 14, 2025.
QuantaSing Group Ltd Schedule 13G/A (Amendment No. 3) confirms that four Qiming-related reporting persons — Qiming Corporate GP VI, Ltd.; Qiming Managing Directors Fund VI, L.P.; Qiming GP VI, L.P.; and Qiming Venture Partners VI, L.P. — no longer beneficially own any Class A Ordinary Shares. The cover-page figures show 0 shares and 0% of the class, and the filing is described as an exit filing for these reporting persons.
The document lists voting and dispositive powers as 0 for each reporting person and states that, as of June 30, 2025, they ceased to beneficially own shares. This filing is a routine disclosure that clarifies institutional ownership status in the issuer’s shareholder register.
Schedule 13D/A Amendment No. 2 highlights a material change in the ownership position of DCM Ventures–affiliated funds in QuantaSing Group Ltd. (NASDAQ: QSG). The venture capital firm and its related entities – Main Fund VIII, Side Fund VIII, Affiliates Fund VIII, their general partners (DCM VIII DGP and DCM VIII UGP) and directors Matthew C. Bonner, F. Hurst Lin, and Andre G. Levi – now beneficially own 24,370,389 Class A ordinary shares represented by 8,123,463 ADSs, equal to 21.4 % of QuantaSing’s outstanding shares (114,114,919 ordinary shares as at 30 June 2025).
The amendment was required after three consecutive open-market sales on 25–27 June 2025 reduced the group’s aggregate ownership by more than one percentage point compared with the previous filing (Amendment No. 1 dated 14 Feb 2025). Specifically, Main Fund VIII, Side Fund VIII and Affiliates Fund VIII disposed of 1,354,575 ADSs (equal to 4,063,725 ordinary shares) for ≈ US$12.24 million in total proceeds at weighted average prices of $9.2065, $8.6348 and $8.0597 per ADS.
Post-transaction holdings are:
- Main Fund VIII: 22,007,410 shares (19.3 %)
- Side Fund VIII: 1,820,446 shares (1.6 %)
- Affiliates Fund VIII: 542,533 shares (0.5 %)
Purpose & future intent: DCM states its investment is for general investment purposes and that it may further buy or sell shares depending on QuantaSing’s performance, market conditions and other opportunities. One director nominee of the funds, Frank Hurst Lin, currently sits on QuantaSing’s board.
Investor takeaway: Although DCM remains QuantaSing’s largest known shareholder, the sizable sale—about 14 % of its prior stake—signals partial profit-taking and could indicate a more flexible stance toward future liquidity events.
QuantaSing Group Ltd. (NASDAQ: QSG) – Form 144 filing dated 06/27/2025 discloses that DCM VIII LP, an investment vehicle whose general partner is identified as a director-level affiliate of the issuer, intends to sell up to 98,001 American Depositary Receipts (ADRs). At the 06/26/2025 closing price implied in the filing, the proposed sale carries an aggregate market value of US$789,858.66. The shares will be brokered through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate execution date of 06/27/2025.
The filing also reports that, during the prior three months, affiliated DCM funds have already sold a combined 188,074 ADRs for gross proceeds of US$1.69 million. Adding the proposed sale would lift total recent dispositions to roughly 286,000 ADRs. For context, QuantaSing has 311,328,381 ADRs outstanding; therefore, the new Form 144 covers about 0.03 % of the float.
The securities being sold were originally acquired on 04/23/2018 in a private transaction with the issuer for cash consideration. The signer, Andre Levi, certifies that no undisclosed material adverse information is known and acknowledges criminal liability for misstatements under 18 U.S.C. §1001.
No financial performance metrics, earnings data or operational updates are included in this notice; the filing strictly concerns a planned secondary sale by an insider-affiliated holder.
Form 144 filing overview: QuantaSing Group Ltd. (NASDAQ: QSG) received a Rule 144 notice dated 06/27/2025 from DCM Affiliates Fund VIII, LP, an affiliate of a QSG director. The fund plans to dispose of 29,190 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney on NASDAQ. The proposed sale is valued at $235,262.64 based on the market price at the time of filing.
Historical selling activity: The same group of related DCM entities disclosed sales on 25-26 June 2025 totaling 188,074 ADRs for aggregate gross proceeds of approximately $1.67 million. All sold securities were ADRs identical to the class now being offered.
Scale relative to outstanding shares: QuantaSing reports 311,328,381 ADRs outstanding. The newly-proposed 29,190-ADR sale equals roughly 0.009 % of shares outstanding, while the recent 3-day sales equal about 0.060 %. Although small in percentage terms, the notice confirms continuing insider-related distributions.
Acquisition background: The securities were originally acquired on 04/23/2018 via a private transaction with the issuer for cash.
Key compliance note: By signing the form, the filer certifies that it is not in possession of undisclosed material adverse information and acknowledges potential liability for misstatements under 18 U.S.C. 1001.
QuantaSing Group Ltd. (QSG) – Form 144 Insider Sale Notice
On 27 June 2025, director-related entity DCM Ventures China Fund (DCM VIII) LP filed a Form 144 indicating its intent to sell up to 1,184,735 American Depositary Shares (ADRs) of QuantaSing Group Ltd. The shares will be placed through Morgan Stanley Smith Barney LLC on the NASDAQ. Based on the filing price reference, the proposed sale has an aggregate market value of US$9.55 million.
The issuer reports 311,328,381 ADRs outstanding; the planned disposition therefore represents roughly 0.38 % of total shares—modest in percentage terms, but sizeable in absolute dollar value. The seller originally acquired the shares on 23 April 2018 via a private, cash-funded transaction with the issuer.
Recent insider activity: Within the last three months, DCM-related entities disposed of a combined 188,074 ADRs over 25-26 June 2025, generating gross proceeds of approximately US$1.67 million. The latest Form 144 signals a continuation—and scale-up—of this selling trend.
Key take-aways for investors:
- Although the sale represents less than 1 % of shares outstanding, it adds incremental supply and may weigh on near-term sentiment.
- Because the filing comes from a director-affiliated fund, markets often view the move as a potential indicator of insider outlook or portfolio re-balancing.
- No adverse, non-public information is acknowledged in the certification, and the company’s operations or guidance are not addressed in this document.
Form 144 filing overview: DCM Ventures China Fund (DCM VIII) LP, identified as a director-level affiliate of QuantaSing Group Ltd. (QSG), has filed a Form 144 to sell up to 98,199 American Depositary Receipts (ADRs) of the company.
Transaction specifics
- Broker: Morgan Stanley Smith Barney LLC (Executive Financial Services, New York, NY).
- Proposed sale date: 26 June 2025.
- Aggregate market value of proposed sale: US $847,928.73.
- Shares outstanding: 311,328,381 ADRs.
- The proposed sale therefore represents roughly 0.03 % of total shares outstanding (calculated from figures provided in the filing).
Recent insider sales (past 3 months):
- DCM VIII LP – 5,926 ADRs for US $54,557.72 (25 Jun 2025).
- DCM Affiliates Fund VIII LP – 1,765 ADRs for US $16,249.47 (25 Jun 2025).
- DCM Ventures China Fund (DCM VIII) LP – 71,641 ADRs for US $659,562.87 (25 Jun 2025).
Combining the prior 79,332 ADRs already sold with the newly-filed 98,199 ADRs brings the potential total insider disposition to 177,531 ADRs, still below 0.1 % of shares outstanding.
The signatory, /s/ Andre Levi, confirms compliance with Rule 144 requirements and states that no undisclosed material adverse information is known. No remarks or special conditions are noted.
Key takeaway for investors: The filing signals additional but quantitatively minor insider selling activity by a director-related fund. Given the very small proportion of shares involved, the event is unlikely to have a material impact on QuantaSing’s share structure or trading dynamics, but investors may monitor if the pattern of sales accelerates.